BIOMAT Database Logo BIOMAT Database Logo

Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E. 1993

I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
Upjohn Company, Kalamazoo, Michigan 49001.

The multifunctional HIV-1 RT (human immunodeficiency virus type 1-reverse transcriptase) enzyme possesses three main functions including the RNA- and DNA-directed DNA polymerases and the RNase H. The bisheteroarylpiperazine U-87201E inhibits the two polymerase functions but not the RNase H. Enzymatic kinetic studies of the HIV-1 RT-catalyzed RNA- and DNA-directed DNA polymerase activities were carried out in order to determine if the inhibitor interferes with either the template:primer or the deoxyribonucleotide triphosphate (dNTP)-binding sites of the enzyme. The data were analyzed using steady-state kinetics, considering that the polymerase reaction is ordered in that the template:primer is added first, followed by the dNTP and that the enzyme functions processively. The data were consistent with the model. The steady-state rate constants for the forward and backward reactions were of similar magnitude for both the RNA- and DNA-catalyzed DNA polymerases and suggest that both functions share the same substrate-binding sites. The dissociation constants for the enzyme-inhibitor and enzyme-substrate-inhibitor complexes were somewhat higher for the DNA-directed DNA polymerase function as compared to the RNA directed one. This indicates that U-87201E is a more potent inhibitor for the RNA-directed DNA polymerase than the DNA-directed DNA polymerase. The pattern of inhibition exerted by U-87201E was noncompetitive with respect to both the nucleic acid and nucleotide-binding sites of the RT enzyme for both the RNA- and DNA-directed DNA polymerases. Hence, U-87201E inhibits these functions by interacting with a site distinct from the template:primer and dNTP-binding sites. HIV-2 RT was insensitive to U-87201E, demonstrating the unique sensitivity of HIV-1 RT to this inhibitor.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D004259 DNA-Directed DNA Polymerase DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. DNA Polymerase,DNA Polymerases,DNA-Dependent DNA Polymerases,DNA Polymerase N3,DNA Dependent DNA Polymerases,DNA Directed DNA Polymerase,DNA Polymerase, DNA-Directed,DNA Polymerases, DNA-Dependent,Polymerase N3, DNA,Polymerase, DNA,Polymerase, DNA-Directed DNA,Polymerases, DNA,Polymerases, DNA-Dependent DNA
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843.
December 1992, Experientia,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
Interaction kinetic characterization of HIV-1 reverse transcriptase non-nucleoside inhibitor resistance.
April 2006, Journal of medicinal chemistry,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
January 1992, Advances in experimental medicine and biology,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
[RILPIVIRINE -- a novel HIV-1 non-nucleoside reverse transcriptase inhibitor].
March 2013, Klinicka mikrobiologie a infekcni lekarstvi,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
HIV-1 reverse transcriptase mutants resistant to nonnucleoside reverse transcriptase inhibitors do not adversely affect DNA synthesis: pre-steady-state and steady-state kinetic studies.
August 2006, Journal of acquired immune deficiency syndromes (1999),
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.
January 1996, Advances in experimental medicine and biology,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase.
February 2008, The Journal of biological chemistry,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
New non-nucleoside reverse transcriptase inhibitor.
January 1995, GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
Mass Spectrometric Characterization of HIV-1 Reverse Transcriptase Interactions with Non-nucleoside Reverse Transcriptase Inhibitors.
January 2016, Biological & pharmaceutical bulletin,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and P A Aristoff, and W G Tarpley, and F Reusser
Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors.
February 2006, Current opinion in investigational drugs (London, England : 2000),
Copied contents to your clipboard!